CSI Market
Sign In | Register

C4 Therapeutics Inc (CCCC) Annual Balance Sheets

Annual · GAAP · USD millions
Access CCCC quarterly Balance Sheets →
Quarterly balance sheet trends provide context on C4 Therapeutics Inc's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent74.60
Marketable Securities, Current SH0.00
Cash & Short-term Investments74.00
Accounts receivable2.40
Other Current Assets173.93
Prepaid Expense And Other Assets Current7.17
Total Current Assets258.11
Equipment/Property/Plant Net4.74
Long-term investments3.44
Other Assets, Noncurrent96.22
Debt Securities Available For Sale Excluding Accrued Interest Current173.93
Debt Securities Available For Sale Excluding Accrued Interest Noncurrent48.56
Operating Lease Right Of Use Asset40.53
Total Assets359.08
Liabilities
Accounts Payable, Current AC0.86
Accrued Liabilities And Other Liabilities13.31
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current18.86
Deferred Revenue, Current DE0.00
Total Current Liabilities33.03
Long-term debt0.00
Total Long-term Debt0.00
Deferred Revenue, Noncurrent DE0.00
Other liabilities, Noncurrent69.46
Operating Lease Liability Current6.37
Operating Lease Liability Noncurrent53.62
Total Liabilities102.49
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock995.22
Retained Earnings / Accumulated Deficit-738.69
Other Equity0.05
Common Stockholder's Equity256.59
Total Stockholder's Equity256.59
Liabilities & Stockholder's Equity359.08
4 historic quarters locked

Sign in to unlock the full C4 Therapeutics Inc balance sheet history.

Sign In Create Free Account

About C4 Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: cccc-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-012000

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.